ALLR CLASS ACTION REMINDER - Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Allarity Therapeutics, Inc. Securities Class Action Robbins LLP is Investigating Allegations that Allarity Therapeutics, Inc. (ALLR) Misled Investors Regarding Dovitinib NDA’s Regulatory Prospects

Allarity Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. November 12, 2024 Deadline to file Lead Plaintiff Motion. Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Allarity Therapeutics, Inc....

Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Allarity Therapeutics, Inc. Robbins LLP is Investigating Allegations that Allarity Therapeutics, Inc. (ALLR) Misled Investors Regarding Dovitinib NDA’s Regulatory Prospects